Zhitong Finance App News, Baiyunshan (00874) issued an announcement. Recently, Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. (hereinafter referred to as “Zhongyi Pharmaceutical”), a wholly-owned subsidiary of the company, received a “Drug Production License” approved and issued by the Guangdong Drug Administration and agreed to entrust Zhongyi Pharmaceutical Co., Ltd., the holding subsidiary of the company, Guangxi Baiyunshan Yingkang Pharmaceutical Co., Ltd. (hereinafter referred to as “Yingkang Pharmaceutical”) to produce Bantong (Sinopharm Standard Z10920040).

According to the announcement, Zhongyi Pharmaceutical has commissioned Yingkang Pharmaceutical to produce pharmaceuticals, which will help the company optimize resource allocation, continue to maintain stable production capacity, and meet market demand. The “Pharmaceutical Production License” was obtained this time, which had no significant impact on the company's current performance.